Skip to content

Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography.

Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography in Patients Undergoing General Anaesthesia With the Use of Rocuronium and Cis-atracurium.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05992090
Enrollment
129
Registered
2023-08-15
Start date
2023-10-10
Completion date
2024-05-29
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade, Residual Neuromuscular Blockade

Keywords

neuromuscular blockade, electromyography, kine-myography, general anaesthesia, rocuronium, cis-atracurium, residual neuromuscular blockade, sugammadex

Brief summary

This study aims to compare two monitoring methods of neuromuscular blockade - Kine-myography and Electromyography. The main questions to answer are: * are electromyography and kine-myography interchangeable * is electromyography linked to fewer fault results * is electromyography using lower energy to stimulate nerves The type of study is a multicentric observational clinical trial. Subjects are patients undergoing general anaesthesia with the use of rocuronium or cis-atracurium. In each patient, the neuromuscular blockade will be monitored using kine-myograph and electromyography simultaneously.

Detailed description

Informed consent will first be obtained from the patient for inclusion in the study. Consent will be obtained during an examination by the anaesthesiologist providing anaesthetic care during surgery in the anteroom of the operating theatre. Once informed consent has been obtained, a routine orientation examination will be performed by the anaesthetist and routine pre-operative preparation (provision of peripheral venous access, risk assessment for airway obstruction, etc.) will be performed. The patient will then be transported to the operating theatre. In the operating room, patient monitoring will be initiated, including the deployment of sensors to monitor the depth of neuromuscular blockade. The KMG sensor will be placed on the right arm and the EMG sensor on the left arm. After deployment of the sensors, upper limb fixation will be performed by the anaesthetic nurse. The fixation will be performed with splints compatible with the operating table. Fixation of the limbs and sensor with adhesive tape will not be used. The anaesthesia will then be induced. Propofol and sufentanil will be administered at the discretion of the anaesthetist providing anaesthetic care. Once sufficient depth of sedation has been induced, calibration of the sensors monitoring the depth of neuromuscular blockade will be performed. After calibration of the sensors, the supramaximal current to the CRF will be recorded. The measurement interval will be set to 20 s. After securing the airway, the interval will be extended to 5 - 15 min according to the nature of the surgery and the discretion of the anaesthesiologist providing anaesthetic care. The number of twitches (PCT) and the Train Of Four (TOF) value will be recorded throughout the procedure. On emergence from anaesthesia, the measurement interval will be set to 1 minute. Once sufficient depth of neuromuscular blockade has been reached to allow extubation, monitoring of the depth of neuromuscular blockade will be discontinued. If during the measurement of the depth of neuromuscular blockade a value is measured that is highly suspected to be in error, this suspicion will be recorded in the CRF with a justification.

Interventions

None listed

Sponsors

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients undergoing surgery under general anaesthesia with the use of cis-atracurium or rocuronium

Exclusion criteria

* patients suffering from neuromuscular diseases * patients with known allergy to rocuronium or cis-atracurium * patients in whom it is impossible to measure the depth of the neuromuscular block on the upper extremities (injuries of the upper extremities, contractures etc.) * patients undergoing surgery positioned on their side * patients with an upper arm injury * patients with acromegaly * patients with Alzheimer's disease * patients with the risk of difficult airways * patients induced into general anaesthesia via the Rapid Sequence Induction method * patients with a weight under 5 kilograms

Design outcomes

Primary

MeasureTime frameDescription
Measurement variabilityFrom sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.A primary aim is to demonstrate that measurement of the depth of neuromuscular blockade using kinemyography is associated with a higher measurement variability than measurement of the depth of neuromuscular blockade using electromyography.

Secondary

MeasureTime frameDescription
supramaximal electric stimulusFrom sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.A secondary aim is to demonstrate that measuring the depth of neuromuscular blockade using kinemyography is associated with a higher supramaximal electric stimulus than measuring the depth of neuromuscular blockade using electromyography.
TOF overestimationFrom sensor calibration til extubation at TOF higher than 90%.Maximum length of measurement is 6 hours.The primary objective of the study is to demonstrate that there is measured higher TOF when using KMG to monitor the depth of neuromuscular blockade compared to using EMG sensor to monitor the depth of neuromuscular blockade.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026